Tenofovir
Generic Name: tenofovir
Manufactured by HETERO DRUGS LTD. Dosage form: TABLET. Route: ORAL. Active ingredients: LAMIVUDINE (300MG/300MG); TENOFOVIR. Application: NDA022459.
Overview
Manufactured by HETERO DRUGS LTD. Dosage form: TABLET. Route: ORAL. Active ingredients: LAMIVUDINE (300MG/300MG); TENOFOVIR. Application: NDA022459.
Dosage
Available as tablet for oral use.
Related Medications
Sticta Pulmonaria
sticta pulmonaria
Absinthium, Aconite Nap, Anacardium Ori, Cuprum Met, Hyoscyamus, Ignatia Amara
absinthium, aconite nap, anacardium ori, cuprum met, hyoscyamus, ignatia amara
Dosage form: LIQUID. Route: ORAL. Active ingredients: ACONITUM NAPELLUS (30 [hp_C]/30[hp_C]); COPPER (30 [hp_C]/30[hp_C]); HYOSCYAMUS NIGER (30 [hp_C]/30[hp_C]); SEMECARPUS ANACARDIUM JUICE (30 [hp_C]/30[hp_C]); STRYCHNOS IGNATII SEED (30 [hp_C]/30[hp_C]); WORMWOOD (30 [hp_C]/30[hp_C]). Category: UNAPPROVED HOMEOPATHIC.
Niraparib
niraparib
11 DESCRIPTION Niraparib is an orally available poly (ADP-ribose) polymerase (PARP) inhibitor. The chemical name for niraparib tosylate monohydrate is 2-{4-[(3S)-piperidin-3-yl]phenyl}- 2H -indazole 7-carboxamide 4-methylbenzenesulfonate hydrate (1:1:1). The molecular formula is C 26 H 30 N 4 O 5 S and it has a molecular weight of 510.61 amu. The molecular structure is shown below: Niraparib tosylate monohydrate is a white to off-white, non-hygroscopic crystalline solid.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.